Microenvironment-Responsive Metal-Phenolic Nanozyme Release Platform with Antibacterial, ROS Scavenging, and Osteogenesis for Periodontitis

Yingying Xu,Yifan Luo,Zhenzhen Weng,Haichang Xu,Wei Zhang,Qun Li,Huijie Liu,Lubing Liu,Yanmei Wang,Xuexia Liu,Lan Liao,Xiaolei Wang
DOI: https://doi.org/10.1021/acsnano.3c01940
IF: 17.1
2023-09-29
ACS Nano
Abstract:Periodontitis is a chronic inflammatory disease deriving from dental plaque, characterized by the excessive accumulation of reactive oxygen species (ROS), matrix metalloproteinase (MMP) and other substances, resulting in the destruction of periodontal tissues. At present, the main therapeutic modalities, such as local mechanical debridement and antibiotic delivery, are not only difficult to solve the intractable bacterial biofilm effectively but also tricky to ameliorate the excessive...
materials science, multidisciplinary,chemistry, physical,nanoscience & nanotechnology
What problem does this paper attempt to address?
The problem that this paper attempts to address is the treatment challenge of periodontitis. Periodontitis is a chronic inflammatory disease caused by dental plaque, characterized by the excessive accumulation of reactive oxygen species (ROS), matrix metalloproteinases (MMP), and other substances, leading to the destruction of periodontal tissues. Current main treatment methods, such as local mechanical debridement and antibiotic delivery, not only struggle to effectively address stubborn bacterial biofilms but also find it difficult to alleviate excessive inflammatory responses and regenerate damaged periodontal tissues. To overcome these limitations, the authors propose a multifunctional nanozyme on-demand release platform (TM/BHT/CuTA) based on copper-tannic acid nanozymes (CuTANSs) and triglycerol monostearate/2,6-di-tert-butyl-4-methylphenol (TM/BHT) hydrogel. This platform has the following features: 1. **Extended residence time**: Through electrostatic adsorption and adhesion, the negatively charged TM/BHT/CuTA can reside at the inflammation site for a long time, avoiding loss due to saliva flow, thereby reducing the frequency of administration and improving practicality. 2. **On-demand release**: In the periodontitis microenvironment, with the increase of MMP, the TM/BHT/CuTA hydrogel can responsively release CuTANSs, achieving on-demand release. 3. **Antibacterial performance**: The released CuTANSs have a broad-spectrum antibacterial effect on periodontitis-related bacteria, especially anaerobic bacteria such as Porphyromonas gingivalis (P. gingivalis). 4. **Multifunctional ROS scavenging ability**: CuTANSs can clear various ROS through a cascade process that mimics superoxide dismutase (SOD) and catalase (CAT). 5. **Anti-inflammatory and osteogenic performance**: By regulating the Nrf2/NF-κB pathway, CuTANSs can convert M1 macrophages to M2 macrophages, reduce pro-inflammatory factors, increase anti-inflammatory factors and the expression of osteogenic genes, thereby alleviating inflammation and accelerating the regeneration of periodontal tissues. In summary, this multifunctional nanozyme on-demand release platform (TM/BHT/CuTA) provides a promising new strategy for the treatment of periodontitis.